Clinical trial
Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
NCT03211741 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema
- Lead sponsor
- University Hospital, Ghent
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 22, 2013
- Completion date
- July 9, 2024
- Enrollment
- 583 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.